Clovis Capital Management’s Dynavax Technologies DVAX Stock Holding History

Clovis Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41,669	Closed	-$165K	–	1
2016 Q4	$165K	Sell	41,669 -126,238	-75%	-$925K	1.69%	7
2016 Q3	$1.76M	Sell	167,907 -248,490	-60%	-$3.57M	0.55%	19
2016 Q2	$6.07M	Sell	416,397 -9,848	-2%	-$168K	2.81%	12
2016 Q1	$8.2M	Buy	426,245 +210,766	+98%	+$4.26M	2.38%	12
2015 Q4	$5.21M	Sell	215,479 -209,521	-49%	-$5.25M	1.36%	18
2015 Q3	$10.4M	Buy	425,000 +325,000	+325%	+$9.2M	2.78%	10
2015 Q2	$2.34M	Sell	100,000 -130,000	-57%	-$2.83M	0.72%	17
2015 Q1	$5.16M	Buy	+230,000	New	+$4.41M	1.45%	20

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Clovis Capital Management's DVAX Position: Q1 2017 in Review

Clovis Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 41,669 shares — an estimated $165K sold.

Clovis Capital Management first reported a position in DVAX in Q1 2015 and held it in 8 quarters. The position peaked at $10.4M in Q3 2015. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

Clovis Capital Management reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
Clovis Capital Management sold 41,669 Dynavax Technologies shares in Q1 2017, an estimated $165K.
Clovis Capital Management first reported a position in Dynavax Technologies in Q1 2015 and held it in 8 quarters.
Clovis Capital Management's Dynavax Technologies position peaked at $10.4M in Q3 2015.
101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on Clovis Capital Management's 13F filing for Q1 2017.